Skip to main content
. 2021 Mar 30;204(10):1180–1192. doi: 10.1164/rccm.202101-0119OC

Figure 6.


Figure 6.

Integrated genomic and immune features across patients with lung adenocarcinoma with different GGO components. ctDNA = circulating tumor DNA; CYT = cytologic activity; GGO = ground-glass opacity; LOH = loss of heterozygosity; MUT = mutation; NSN = nonsolid nodule; PSN = part-solid nodule; SN = solid nodule; TMB = tumor mutation burden.